Jennifer Doan

Array ( [id] => 6940014 [patent_doc_number] => 20050113577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Solid forms of slats with tyrosine kinase activity' [patent_app_type] => utility [patent_app_number] => 10/506710 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13305 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113577.pdf [firstpage_image] =>[orig_patent_app_number] => 10506710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639970 [patent_doc_number] => 20030212076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Fibrinogen receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/410826 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6617 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212076.pdf [firstpage_image] =>[orig_patent_app_number] => 10410826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770446 [patent_doc_number] => 20030216386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8' [patent_app_type] => new [patent_app_number] => 10/410837 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9158 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216386.pdf [firstpage_image] =>[orig_patent_app_number] => 10410837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676934 [patent_doc_number] => 20080214565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Oxazolidinone Derivatives as Antimicrobials' [patent_app_type] => utility [patent_app_number] => 10/552322 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10721 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214565.pdf [firstpage_image] =>[orig_patent_app_number] => 10552322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7139062 [patent_doc_number] => 20050182256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Inhibitors of akt activity' [patent_app_type] => utility [patent_app_number] => 10/509959 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22205 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182256.pdf [firstpage_image] =>[orig_patent_app_number] => 10509959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040574 [patent_doc_number] => 20050159422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Inhibitors of akt activity' [patent_app_type] => utility [patent_app_number] => 10/510066 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22327 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159422.pdf [firstpage_image] =>[orig_patent_app_number] => 10510066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098518 [patent_doc_number] => 20050130977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Inhibitors of akt activity' [patent_app_type] => utility [patent_app_number] => 10/510067 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19651 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130977.pdf [firstpage_image] =>[orig_patent_app_number] => 10510067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432330 [patent_doc_number] => 07265103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Substituted amino isoxazoline derivatives and their use as anti-depressants' [patent_app_type] => utility [patent_app_number] => 10/510220 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15003 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265103.pdf [firstpage_image] =>[orig_patent_app_number] => 10510220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050149 [patent_doc_number] => 06861428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Water-soluble phenylpyridazine compounds and compositions containing the same' [patent_app_type] => utility [patent_app_number] => 10/396726 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 68582 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 587 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861428.pdf [firstpage_image] =>[orig_patent_app_number] => 10396726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180956 [patent_doc_number] => 20050124628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 10/509078 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14456 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124628.pdf [firstpage_image] =>[orig_patent_app_number] => 10509078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664584 [patent_doc_number] => 20030203910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Novel compounds for enhancing chemotherapy' [patent_app_type] => new [patent_app_number] => 10/396070 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18382 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203910.pdf [firstpage_image] =>[orig_patent_app_number] => 10396070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 975770 [patent_doc_number] => 06933387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-23 [patent_title] => 'Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles' [patent_app_type] => utility [patent_app_number] => 10/396242 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37752 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933387.pdf [firstpage_image] =>[orig_patent_app_number] => 10396242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180950 [patent_doc_number] => 20050124626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 10/509077 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10490 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124626.pdf [firstpage_image] =>[orig_patent_app_number] => 10509077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918767 [patent_doc_number] => 20050096328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa' [patent_app_type] => utility [patent_app_number] => 10/486138 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4752 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096328.pdf [firstpage_image] =>[orig_patent_app_number] => 10486138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741527 [patent_doc_number] => 07030115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'N-sulfonylurea apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 10/394985 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14867 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030115.pdf [firstpage_image] =>[orig_patent_app_number] => 10394985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664762 [patent_doc_number] => 20030204089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => new [patent_app_number] => 10/385522 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10991 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20030204089.pdf [firstpage_image] =>[orig_patent_app_number] => 10385522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1169849 [patent_doc_number] => 06753336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-22 [patent_title] => 'Melanin concentrating hormone receptor ligands' [patent_app_type] => B2 [patent_app_number] => 10/385973 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10602 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 295 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753336.pdf [firstpage_image] =>[orig_patent_app_number] => 10385973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1210311 [patent_doc_number] => 06713626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-30 [patent_title] => 'Process for synthesizing N-aryl piperazines with chiral N-1-benzoyl(2-pyridyl)amino-2-propane substitution' [patent_app_type] => B2 [patent_app_number] => 10/384845 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3647 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713626.pdf [firstpage_image] =>[orig_patent_app_number] => 10384845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825637 [patent_doc_number] => 20030236259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Novel aryl- and heteroarylpiperazines' [patent_app_type] => new [patent_app_number] => 10/383310 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34328 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236259.pdf [firstpage_image] =>[orig_patent_app_number] => 10383310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1301220 [patent_doc_number] => 06624304 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Process for preparing a 10,11-methanodibenzosuberane derivative' [patent_app_type] => B1 [patent_app_number] => 10/378436 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5623 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624304.pdf [firstpage_image] =>[orig_patent_app_number] => 10378436 [rel_patent_id] =>[rel_patent_doc_number] =>)